APLS vs MKC · rev $781.4M vs P/E 8.4, rev $3.81B
Apellis Pharmaceuticals Inc (APLS) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
Latest reported MKC revenue for 2026-05-31 was $3.81B. Net income was $1.17B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
APLS currently screens at market cap $2.29B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the APLS and MKC stock pages for the full models.
Not investment advice.